DIMER INSTRUMENTS, INC.

DIMER INSTRUMENTS, INC. has raised $7.5M in total funding. The most recent round was Series A.

DIMER INSTRUMENTS, INC. is headquartered in Santa Barbara, CA.

Pharmaceutical companies need real-time molecular analysis at multiple points in drug development to move faster while achieving higher product quality and consistency, including measuring protein stability, binding affinity, and expression levels.

Dimer builds a line of lab instruments (Prometheus, Monolith, Dianthus, Andromeda) that provide real-time molecular analysis for stability, binding affinity screening, and protein expression optimization during pharmaceutical development.

The page cites specific technical claims per product, such as Dianthus's Spectral Shift technology for affinity screening that avoids immobilization pitfalls, and Monolith's ultra-low sample consumption for validating binding results other methods fail to capture.